Moderna, Inc. (MRNA) Revenue History
Moderna, Inc. (MRNA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2018-12-31 | $135.07M |
| 2019-12-31 | $60.21M |
| 2020-12-31 | $803.00M |
| 2021-12-31 | $18.47B |
| 2022-12-31 | $19.26B |
| 2023-12-31 | $6.85B |
| 2024-12-31 | $3.24B |
| 2025-12-31 | $1.94B |
How MRNA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| VREX | Varex Imaging Corporation | $844.60M |
| ARWR | Arrowhead Pharmaceuticals Inc. | $829.45M |
| MYGN | Myriad Genetics Inc. | $824.50M |
| USPH | U.S. Physical Therapy Inc. | $780.99M |
| NEO | NeoGenomics Inc. | $727.33M |
These are five companies in the same sector as MRNA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Moderna, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("MRNA", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MRNA | $225.00 | +14.21% | 28.83M |
| 3 | ||||
| 4 | ||||
| 5 |